Regard vs PathAI
Detailed side-by-side comparison to help you choose the right tool
Regard
🟢No CodeAI Healthcare
AI clinical insights platform that reviews 100% of patient chart data to recommend diagnoses, generate draft documentation, and surface missed conditions at the point of care.
Was this helpful?
Starting Price
PaidPathAI
🟢No CodeAI Healthcare
AI-powered digital pathology platform providing FDA-cleared diagnostic tools, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.
Was this helpful?
Starting Price
EnterpriseFeature Comparison
Scroll horizontally to compare details.
Regard - Pros & Cons
Pros
- ✓Reviews 100% of patient chart data — catches conditions that clinicians miss when manually reviewing the 3% they have time for
- ✓Generates draft clinical documentation before the physician encounter, saving 10+ minutes per note
- ✓Proven revenue impact: Sentara Health saw 17% increase in CC/MCC capture with 4x ROI per user
- ✓Integrates directly into Epic and Cerner workflows — no context-switching to a separate application
- ✓Reduces CDI query burden by proactively documenting diagnoses, saving CDI teams ~60 minutes per avoided query
- ✓Combines ambient conversation data with chart data for more complete clinical picture
- ✓HIPAA-compliant with enterprise-grade security appropriate for hospital environments
Cons
- ✗Enterprise-only pricing with no self-service tier — requires a sales process and implementation timeline
- ✗Currently focused on hospital medicine (hospitalists/internists) — limited applicability for outpatient or specialty practices
- ✗Implementation requires EHR integration work that can take weeks to months depending on the health system's IT infrastructure
- ✗Physician adoption depends on trust in AI-generated suggestions — some clinicians may resist AI-recommended diagnoses
PathAI - Pros & Cons
Pros
- ✓FDA 510(k) clearance for AISight Dx with PCCP enables regulatory-compliant AI diagnostics
- ✓Trained on 15M+ pathologist-verified annotations across multiple cancer types
- ✓Used by 90% of the top 15 biopharma companies for clinical trial pathology
- ✓Cloud-native architecture enables remote pathology consultation and collaboration
- ✓Integrated end-to-end offering from tissue processing through AI-powered diagnosis
- ✓Precision Pathology Network creates collaborative ecosystem for labs and pharma
Cons
- ✗Enterprise-only pricing excludes small independent pathology practices
- ✗Requires significant infrastructure investment for whole-slide image scanning and storage
- ✗Limited to anatomic pathology — does not cover clinical laboratory testing or radiology
- ✗Long implementation timelines typical of enterprise healthcare IT deployments
Not sure which to pick?
🎯 Take our quiz →🔒 Security & Compliance Comparison
Scroll horizontally to compare details.
🦞
🔔
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.